DRKS00013557已完成未知
Impact of Open Label Placebo Administration on Cognition and Well-being - OLP KOBEF
niversitätsklinikum EssenKlinik für Neurologie0 个研究点目标入组 167 人开始时间: 2017年12月20日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 167
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized controlled study
- 盲法
- Blinded (masking used)
入排标准
- 年龄范围
- 18 Years 至 60 Years（—）
- 性别
- All
入选标准
- •Age> 18 years, successfully completed registration for the first attempt of the examination of the first section of Medicine (M1) or a comparable examination of another study section or course, Volunteers, informed consent to study participation
排除标准
- •Severe medical conditions (in particular, diagnosed psychiatric comorbidities, in particular harmful substance abuse (including alcohol, cannabinoids, cocaine, amphetamines) in the last 4 weeks prior to inclusion or persistence; Known allergy or intolerance to any of the ingredients of the placebo; Parallel participation in a study using investigational medicinal products.
研究者
相似试验
已完成
不适用
The influence of open-label placebos on cognitive performanceHealthy volunteersDRKS00019203niversitätsklinik Essen AöR Klinik für Neurologie88
尚未招募
Unknown
What are the effects of an open-label placebo on pain?ACTRN12623000801617The University of Auckland42
已完成
不适用
Effect of open-label placebos on health status in patients with painful knee joint arthrosis - a randomized controlled trialchronic knee pain in knee joint arthrosis (Kellgren II - III)DRKS00015191Institut für Medizinische Psychologie, LMU München60
已完成
Unknown
Effects of an Open-label Placebo Intervention on Reactions to Social Exclusion in Healthy Adults: A Randomized Controlled TrialHealthy subjectsDRKS00031399niversität Basel74
招募中
不适用
The impact of a 12-week open-label placebo treatment on headache days in episodic and chronic migraine: A randomized controlled trialG43.9Migraine, unspecifiedDRKS00021259niversitätsklinikum EssenKlinik für Neurologie150